Literature DB >> 6692367

Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells.

R Jakesz, C A Smith, S Aitken, K Huff, W Schuette, S Shackney, M Lippman.   

Abstract

In the present study, the effects of cell cycle phase and proliferation rate on the expression of specific estrogen binding activity were explored in hormone-dependent human breast cancer cells. A technique was developed to alter the proliferative rate of MCF-7 cells by plating at different densities. The doubling time ranged from 20 to 48 hr, showing a negative relation to the number of plated cells. Slowly proliferating cells had accumulated more than twice as much estrogen receptor (ER) activity as did fast-proliferating cells. Exposure of exponentially growing cells to isoleucine-deficient medium resulted in decreased thymidine incorporation and disappearance of detectable cellular ER activity. Overall protein synthesis was reduced by only 30% in cells growing in isoleucine-free medium. At 24 hr after release from isoleucine deprivation, ER levels are fully restored, although thymidine incorporation does not resume for an additional 6 to 8 hr, and increases in cell number are not seen for 24 hr. Exposure of exponentially growing cells to 2 mM thymidine for 24 hr produced partially synchronized MCF-7 cells (approximately 70%). Six hr after release from excess thymidine, cells reached S phase; after 9 hr, G2; and after 18 hr, G1. ER levels immediately and, 6 hr after release, remained unchanged, showed a slight increase at 9 hr, and showed an increase of about 50 to 60% at 18 hr. These data suggest that: (a) ER binding activity and DNA synthesis can be dissociated; (b) ongoing protein synthesis is necessary for maintenance of cellular ER activity; and (c) ER is apparently synthesized throughout the cell cycle, with some evidence that this is predominantly in G1 and G2.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692367

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Decreased plasma and tissue isoleucine levels after simulated gastrointestinal bleeding by blood gavages in chronic portacaval shunted rats.

Authors:  S W Olde Damink; C H Dejong; N E Deutz; P B Soeters
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Effect of histone H1 on estrogen receptor status of human breast cancer MCF 7 cells.

Authors:  G Vani; C S Shyamala Devi
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferon.

Authors:  G Sica; G Dell'Acqua; F Iacopino; A Fattorossi; P Marchetti; T H van der Kwast; M Pavone-Macaluso
Journal:  Urol Res       Date:  1994

4.  DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.

Authors:  T Yokoe; M Izuo; T Ishida; Y Iino; T Kawai
Journal:  Jpn J Surg       Date:  1990-09

5.  Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1.

Authors:  G Flouriot; H Brand; S Denger; R Metivier; M Kos; G Reid; V Sonntag-Buck; F Gannon
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

6.  8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer.

Authors:  M E Lippman; R B Dickson; S Bates; C Knabbe; K Huff; S Swain; M McManaway; D Bronzert; A Kasid; E P Gelmann
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

7.  Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor.

Authors:  S M Rink; K J Yarema; M S Solomon; L A Paige; B M Tadayoni-Rebek; J M Essigmann; R G Croy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

8.  Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy.

Authors:  R Jakesz; C Dittrich; J Hanusch; R Kolb; R Lenzhofer; K Moser; H Rainer; G Reiner; M Schemper; J Spona
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

9.  Oleanolic acid and ursolic acid inhibit proliferation in transformed rat hepatic oval cells.

Authors:  Yu-Ying Han; Xiao-Wei Xue; Zheng-Ming Shi; Peng-Yan Wang; Xin-Rui Wu; Xue-Jiang Wang
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer.

Authors:  M A Fanelli; L M Vargas-Roig; F E Gago; O Tello; R Lucero De Angelis; D R Ciocca
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.